Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - MESA LABORATORIES INC /CO/ | mlab20200331b_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - MESA LABORATORIES INC /CO/ | ex_172220.htm |
| EX-32.1 - EXHIBIT 32.1 - MESA LABORATORIES INC /CO/ | ex_172219.htm |
| EX-31.2 - EXHIBIT 31.2 - MESA LABORATORIES INC /CO/ | ex_172218.htm |
| EX-31.1 - EXHIBIT 31.1 - MESA LABORATORIES INC /CO/ | ex_172217.htm |
| EX-23.2 - EXHIBIT 23.2 EKSH CONSENT - MESA LABORATORIES INC /CO/ | ex_188415.htm |
| EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES - MESA LABORATORIES INC /CO/ | ex_186247.htm |
| EX-4.3 - EXHIBIT 4.3_DESCRIPTION OF EQUITY - MESA LABORATORIES INC /CO/ | ex_187542.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Mesa Laboratories, Inc.’s Registration Statements on Form S-3 (File Nos. 333-233042 and 333-225451) and Form S-8 (File Nos. 333-206551, 333-186893, and 333-152210) of our report dated June 1, 2020, relating to the March 31, 2020 and 2019 consolidated financial statements and the effectiveness of internal control over financial reporting of Mesa Laboratories, Inc., which appears in this Annual Report on Form 10-K.
/s/ Plante & Moran, PLLC
Denver, Colorado
June 1, 2020